A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

ClinicalTrials.gov ID: NCT07548632

Public ClinicalTrials.gov record NCT07548632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 4, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b/3, Double-masked, Randomized, Vehicle-controlled, Multicenter Study Evaluating Licaminlimab in Dry Eye Disease Patients With a Specific TNFR1 Genotype

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.

Study identification

NCT ID: NCT07548632
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Oculis; Industry
Enrollment: 160 participants

Conditions and interventions

Conditions

Dry Eye Disease (DED)

Interventions

Other · Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 15, 2026
Primary completion: Nov 30, 2026
Completion: Nov 30, 2026
Last update posted: Aug 27, 2026

2026

United States locations

U.S. sites: 14
U.S. states: 7
U.S. cities: 14

Facility	City	State	ZIP	Site status
East West Eye Institute	Aliso Viejo	California	92656	Recruiting
Orange County Ophthalmology	Garden Grove	California	92843	Recruiting
Global Research Management	Glendale	California	91204	Recruiting
LoBue Laser and Eye Medical Center	Murrieta	California	92562	Recruiting
Eye Research Foundation	Newport Beach	California	92664	Recruiting
North Bay Eye Associates, Inc.	Petaluma	California	94954	Recruiting
Vision Institute	Colorado Springs	Colorado	80907	Recruiting
Segal Drug Trials, Inc.	Delray Beach	Florida	33484	Active, not recruiting
Oculus Research, Inc.	Garner	North Carolina	27529	Recruiting
CORE, Inc	Shelby	North Carolina	28150	Recruiting
Scott & Christie and Associates	Cranberry Township	Pennsylvania	16066	Active, not recruiting
Erie Retina Research	Erie	Pennsylvania	16507	Recruiting
Total Eye Care, PA	Memphis	Tennessee	38119	Recruiting
Piedmont Eye Center, Inc.	Lynchburg	Virginia	24502	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07548632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 27, 2026 · Synced Sep 4, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07548632 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →